Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

LABETALOL HYDROCHLORID

Closed
SPE2DP-26-T-4424Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Labetalol Hydrochloride Injection USP, 5 mg per mL in 40 mL vials, is being procured under solicitation SPE2DP-26-T-4424 for the Department of Defense through the Medical Supply Chain Pharm FSA. The product is manufactured by Hikma Pharmaceuticals USA Inc. with NDC 00143-9623-01 and is regulated by the FDA. Each vial contains 40 mL and is packaged as one vial per unit, with a total requirement of four vials. The item has a non-extendable shelf life of 24 months and must comply with the latest Medical Marking Standard No. 1. Packaging must adhere to MIL-STD-2073-1E and be stored at medical controlled room temperature. All supplies must be marked in accordance with DLA requirements, including the removal of government identification from non-accepted items. The delivery is FOB destination within five days of award, with zero tolerance for quantity variance, and inspection and acceptance occur at the destination. The contract specifies the NSN 6505012579990 and is subject to the DLA Master List of Technical and Quality Requirements, with applicable technical and quality specifications incorporated by reference. The point of contact for this solicitation is James McCullough, and responses are due by August 10, 2026.

General Info

Labetalol HCl injection, 5 mg/mL, 40 mL vials, 4 units, FDA-regulated, Hikma, FOB destination, 24-month shelf life, DLA compliance.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4424 Medical Supply Chain Pharma FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
LABETALOL HYDROCHLORIDE INJECTION
LABETALOL HYDROCHLORIDE INJECTION<(>,<)> USP. 5 MG PER ML<(>,<)> 40 ML.
1 VI = 40 ML. STORE AT MEDICAL CONTROLLED ROOM TEMPERATURE.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
INCLUDE RD003 OBJECT TEXT ID ST
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
HIKMA PHARMACEUTICALS USA INC. 32655 P/N NDC00143-9623-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017513543 0001 VI 4.000
NSN/MATERIAL:6505012579990
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
SPE2DP-26-T-4424
SECTION B
PR: 7017513543 PRLI: 0001 CONT’D
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-257-9990 Quantity: 4 VI Purchase Request: 7017618337QTY: 4 Delivery: 5 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS